Ignite Creation Date:
2025-12-25 @ 12:27 AM
Ignite Modification Date:
2026-01-02 @ 2:36 AM
Study NCT ID:
NCT04009967
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-01-13
First Post:
2019-06-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Biomarkers for Neoadjuvant Pembrolizumab in Non-Metastatic Prostate Cancer Positive by 18FDG-PET Scanning
Sponsor:
CHU de Quebec-Universite Laval
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-01-10
Start Date Type:
ACTUAL
Primary Completion Date:
2024-09-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-03-30
Completion Date Type:
ESTIMATED
First Submit Date:
2019-06-17
First Submit QC Date:
None
Study First Post Date:
2019-07-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-10
Last Update Post Date:
2025-01-13
Last Update Post Date Type:
ACTUAL